The International Centre for Diarrhoeal Disease Research, Bangladesh
Dhaka, Bangladesh
NCT Number: NCT02745327
The purpose of this study is to assess the impact of small intestine bacterial overgrowth (SIBO) on childhood nutritional status, growth, and oral vaccine efficacy.
Looking for future studies?
Notify Me1 day–7 day
All sexes
Observational
Dhaka, Bangladesh
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Birth to 2 years
Test for Small Intestine Bacterial Overgrowth
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: 12 weeks of age
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
Time frame: Birth to 2 years
University of Virginia
Other
A Longitudinal Study of Childhood Intestinal Bacterial Overgrowth, Vaccine Underperformance, and Malnutrition
Acronym: NOVEL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07451171
Small Intestine Bacterial Overgrowth
Dhaka, Bangladesh
View Trial DetailsNCT06518850
Small Intestine Bacterial Overgrowth
View Trial Details